STAT
MAY 17, 2024
The Biden administration announced new programs on May 10 to incentivize dairy farmers and workers to collaborate with public health efforts to investigate and mitigate the H5N1 avian influenza outbreak among dairy cattle. Farmers and agriculture officials have called such testing “overreach,” telling public health officials to “back off.
PharmaVoice
MAY 14, 2024
The old guard of pharma bestsellers is seeing more competition, but newer drugs demonstrating sales and revenue growth can build up the coffers in years to come.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharmacist
MAY 15, 2024
The equivalent of 10 local pharmacies are closing their doors each week, according to analysis by the National Pharmacy Association (NPA). And the number of bricks and mortar pharmacies closing between January and April 2024 is nearly 50% higher than in the same period last year, the NPA said. The association’s analysis of NHS Business […] The post Ten pharmacies closing every week, NPA analysis suggests appeared first on The Pharmacist.
Pharmafile
MAY 17, 2024
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have had disease progression on or after platinum-based chemotherapy. The post FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer appeared first on Pharmafile.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
BioPharma Dive
MAY 13, 2024
Goldman Sachs and Eli Lilly are among those backing the startup, which claims its prospect could be more potent than the myelofibrosis therapies that have come to market in recent years.
STAT
MAY 16, 2024
There are so few Indigenous physicians in the United States — just 0.3% of doctors — that their numbers barely show up in charts and graphs depicting the diversity of the medical workforce. But as of Thursday, there will be at least nine more. Thursday is graduation day for the first class of the nation’s only tribally affiliated medical school, the Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
MAY 15, 2024
GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.
The Pharmacist
MAY 16, 2024
National Pharmacy Association (NPA) leaders have delivered a giant invoice for the £108m they say is owed to the sector for dispensing at a loss over the last month. And pharmacy owners can generate their own individual invoice using a new tool launched by the NPA, which indicates the funding shortfall for each pharmacy based […] The post NPA hands DHSC giant invoice for '£108m monthly shortfall' appeared first on The Pharmacist.
BioPharma Dive
MAY 15, 2024
The annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of Leqembi for approval, looks “more realistic” than previous guidance, according to Jefferies analysts.
STAT
MAY 16, 2024
As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having to go without basic medications to control their child’s asthma. At least seven children have died due to uncontrolled asthma this year in the Philadelphia region, a dramatic increase from prior years.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
EMCrit Project
MAY 16, 2024
Piperacillin-tazobactam is an antibiotic that a lot of people love to hate. Combine this with the conservatism that often (rightfully) surrounds drug safety, and it creates a lot of volatility. Before going further, we should review some recent history regarding piptazo. In the early 2010's, a series of retrospective correlational studies found that patients treated […] EMCrit Project by Josh Farkas.
pharmaphorum
MAY 13, 2024
Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy. The option fee could be followed by another up to $2.1 billion in potential milestones if Takeda takes global rights to the programme, currently headed by ACI-24.060 which is in a phase 1b/2 trial with new data due in the next few weeks.
The Pharmacist
MAY 14, 2024
Community Pharmacy England (CPE) has already begun working with the Department of Health and Social Care (DHSC) on how hub and spoke arrangements will work for NHS services in England, it has told The Pharmacist. This comes as the government plans to allow models of hub and spoke dispensing across different legal entities that could supply […] The post CPE 'already working with DHSC' on implications of hub and spoke changes appeared first on The Pharmacist.
BioPharma Dive
MAY 16, 2024
While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.
STAT
MAY 15, 2024
WASHINGTON — It’s Friday May 10, and I’m on my way to what feels like the world’s weirdest drug deal. I received a text the day before from a man named Karl. My order would be arriving from Maryland between 2 and 4 p.m. at the northwest D.C. drop site. It’ll be safely wrapped in ice packs, he assured me.
Express Pharma
MAY 17, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of type 2 diabetes and obesity. With the obesity and type 2 diabetes markets growing at unprecedented rates, the GLP-1 receptor agonists market is also growing. GLP-1 receptor agonist sales for the type 2 diabetes and obesity markets are forecast to reach over $125 billion in the seven major markets (7MM*) by 2033, according to GlobalData.
pharmaphorum
MAY 14, 2024
The Institute for Clinical and Economic Review (ICER) typically focuses on the cost-effectiveness of new therapies, but in an unusual move has sharply criticised the design and conduct of clinical trials of Lykos Therapeutics psychedelic therapy for post-traumatic stress disorder (PTSD).
The Pharmacist
MAY 13, 2024
Hub and spoke dispensing between pharmacies owned by different legal entities will be allowed from 1 January 2025, subject to parliamentary approval, the government has announced. In its consultation response published today, the government proposed introducing two models of hub and spoke dispensing across legal entities. In one model the hub would directly supply the […] The post BREAKING: Government publishes hub and spoke consultation response appeared first on The Pharmacist.
FDA Law Blog: Biosimilars
MAY 13, 2024
By Jeffrey N. Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). Extolling RWE, FDA has said “RWE can be leveraged to bring new products to market, evaluate the safety and effectiveness of existing products for new uses, and assess the continued performance and safety of products once on the market.
STAT
MAY 15, 2024
WASHINGTON — The Biden administration has suspended federal grants issued to EcoHealth Alliance, the infectious disease research group caught up in a controversy over its work in China, and plans to bar it from receiving future funding. The Health and Human Services Department dispatched its decision in a letter Tuesday , two weeks after House lawmakers grilled EcoHealth President Peter Daszak on the nonprofit’s research, oversight, and safety measures, particularly its work with t
Pharmaceutical Commerce
MAY 15, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.
pharmaphorum
MAY 16, 2024
Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.
Express Pharma
MAY 17, 2024
Glenmark Pharmaceuticals has received final approval by the USFDA for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%. Glenmark’s Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% has been determined by the FDA to be bioequivalent and therapeutically equivalent (1) to Combigan (2) Ophthalmic Solution, 0.2%|0.5%, of AbbVie, and will be distributed in the US by Glenmark Pharma Inc., USA.
BioPharma Dive
MAY 16, 2024
Full study results disclosed ahead of a medical meeting showed elinzanetant consistently reduced the frequency and severity of hot flashes.
STAT
MAY 14, 2024
WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food. Scott Gottlieb, the commissioner of the Food and Drug Administration at the time, grinned widely as he held liquid egg whites and a carton of eggs.
Pharma Times
MAY 16, 2024
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
pharmaphorum
MAY 17, 2024
Brainomix gets FDA approval for e-Lung, an AI tool that assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical images.
The Pharmacist
MAY 16, 2024
Health spending has grown ‘by less than planned’ since the last general election, with cash top-ups ‘insufficient’ to offset inflation, a leading think tank has found. Plans set out in the 2019 election campaign indicated the DHSC budget would increase by 3.3% a year above inflation, however spending has risen by only 2.7% a year […] The post Health spending has grown less than planned, finds IFS report appeared first on The Pharmacist.
Express Pharma
MAY 17, 2024
Biogen and Ionis Pharmaceuticals announced the decision to terminate development of BIIB105 (ION541) an investigational antisense oligonucleotide (ASO) for amyotrophic lateral sclerosis (ALS) based on topline results from the Phase 1/2 ALSpire study. BIIB105 was designed to reduce expression of ataxin-2 (ATXN2) protein and demonstrated statistically significant cerebrospinal fluid (CSF) ATXN2 protein reductions in the study.
STAT
MAY 16, 2024
Higher ranking military officers receive more resources and better care than low ranking military officers, according to an analysis of 1.5 million military ER visits published Thursday in the journal Science. The study also showed that white physicians expended less effort on Black patients, even when rank was taken into account: Higher ranking Black officers received care from white physicians that was similar to that received by lower ranking white officers.
Pharmaceutical Commerce
MAY 17, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
pharmaphorum
MAY 14, 2024
Bayer's first-quarter results update shows its headcount has shrunk by around 1,500 since the start of the year, suggesting promised job cuts are starting to take hold
The Pharmacist
MAY 14, 2024
NHS England (NHSE) wants Additional Roles Reimbursement Scheme (ARRS) funding that has recently been unlocked for designated prescribing practitioners (DPPs) ‘to support trainee pharmacists across sectors of practice’, a conference has heard. Last week at the Clinical Pharmacy Congress (CPC) in London, a new opportunity to use ARRS funding for pharmacy training roles was announced. […] The post ARRS funding for DPPs could support community trainees appeared first on The Pharmacist.
Express Pharma
MAY 15, 2024
To understand opportunities and challenges in the evolving Asia-Pacific healthcare landscape, Bain & Company conducted a survey in Q4 2023 to uncover consumer-centric trends in healthcare consumption. The survey was distributed to 2,300 consumers across nine Asia-Pacific geographies (Australia, China, Hong Kong, India, Indonesia, Malaysia, Philippines, Singapore, and Vietnam) in a process similar to the data collections we conducted previously in 2019 and 2021.
STAT
MAY 13, 2024
Reluctance among dairy farmers to report H5N1 bird flu outbreaks within their herds or allow testing of their workers has made it difficult to keep up with the virus’s rapid spread , prompting federal public health officials to look to wastewater to help fill in the gaps. On Monday, the Centers for Disease Control and Prevention is expected to unveil a public dashboard tracking influenza A viruses in sewage that the agency has been collecting from 600 wastewater treatment sites around the
Expert insights. Personalized for you.
356 
Let's personalize your content